Role of Rho-kinase in regulation of insulin action and glucose homeostasis.
Journal
  Cell metabolism.
Citation
  Cell Metab. 2(2):119-29
Publication date
  2005 Aug
Authors
  Furukawa N
Ongusaha P
Jahng WJ
Araki K
Choi CS
Kim HJ
Lee YH
Kaibuchi K
Kahn BB
Masuzaki H
Kim JK
Lee SW
Kim YB
Investigators
  Jason K. Kim
Grant agencies
  National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
Public Health Service
Grants
  NCI CA107574
NCI R01 CA85681
NIDDK R01 DK43051
PHS R01-2005-000-10386
MeSH headings
  Glucose
Homeostasis
Insulin
Protein-Serine-Threonine Kinases
MeSH qualifiers
  metabolism
Abstract
  Accumulating evidence indicates an important role for serine phosphorylation of IRS-1 in the regulation of insulin action. Recent studies suggest that Rho-kinase (ROK) is a mediator of insulin signaling, via interaction with IRS-1. Here we show that insulin stimulation of glucose transport is impaired when ROK is chemically or biologically inhibited in cultured adipocytes and myotubes and in isolated soleus muscle ex vivo. Inactivation of ROK also reduces insulin-stimulated IRS-1 tyrosine phosphorylation and PI3K activity. Moreover, inhibition of ROK activity in mice causes insulin resistance by reducing insulin-stimulated glucose uptake in skeletal muscle in vivo. Mass spectrometry analysis identifies IRS-1 Ser632/635 as substrates of ROK in vitro, and mutation of these sites inhibits insulin signaling. These results strongly suggest that ROK regulates insulin-stimulated glucose transport in vitro and in vivo. Thus, ROK is an important regulator of insulin signaling and glucose metabolism.